Atlas Trials

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

Clinical trial NCT00448916 · COMPLETED

Trial details

NCT number
NCT00448916
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Epilepsies, Partial
Start date
2007-05-01
Primary completion
2013-10-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.